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A heterologous antithymopoietin (anti-TP) antibody 
was used to determine whether a TP-like molecule is 
present in the epidermis, since such factors have been 
postulated to play a part in known T cell-epidermal cell 
interaction. Examination of cytocentrifuge smears of 
freshly separated human epidermal cells stained by in-
direct immunofluorescence revealed that 8-14% of 
these cells possessed cytoplasmic reactivity with the 
anti-TP antibody. Similarly, 2-5% of human epidermal 
cells, maintained in tissue culture for 2-8 weeks, 
showed cytoplasmic staining with the anti-TP antibody. 
Double-labeling immunofluorescence studies, with the 
anti-TP antibody and a monoclonal antibody specifically 
reactive with Langerhans cells (OKT6), demonstrated 
that cells possessing this TP-like substance were not 
Langerhans cells. In situ studies of 4 -J.Lm frozen sections 
of normal human skin indicated that the cell population 
which possesses the TP-like substance is the basal layer 
of keratincoytes in the epidermis. 
Substantial evidence suggests a close relationship between 
the thymus and the skin. Structurally the thymus and skin 
have certain similarities. Epidermal keratinocytes and epithe-
lial cells of Hassall's corpuscles express cross-reactive differ-
entiation antigens [1], and the core of the Hassall 's corpuscle 
is composed of keratin (2). A possible genetic link between 
thymic and cutaneous epithelium is observed in the nude mouse 
which has both deficient thymic development and impaired 
differentiation of hair, an epidermal appendage [3). In addition, 
the only human malignancy regularly shown to be a prolifera-
tion of helper T cells, cutaneous T -cell lymphoma, usually 
presents with infiltration of the skin (4). 
Functionally the skin has been shown to exert an inductive 
effect in vitro on T -cell differentiation resembling that previ -
ously seen within the thymus [5]. Rubenfeld et a l demonstrated 
that cultured epidermal cells induced syngeneic murine bone 
marrow stem cells to express both a marker of early T-cell 
differentiation (terminal deoxyribonucleotidyl transferase) [6] 
and Thy-1, a differentiation marker carried by thymocytes and 
mature T cells (7) . 
The mechanisms of these, and other T cell- epiaermal inter-
actions remain to be elucidated, but it appears that the skin 
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produces soluble mediators t hat exert various effects on other 
cells. Luger et a! [8] have identified a substance, produced by 
cultured keratinocytes, which induces DNA synthesis in thy-
mocytes, although induction of further T-ce11 differentiation 
by th is substance has not been studied. Furthermore, the serum 
of patients with cutaneous T-celllymphoma contains a potent 
T cell-inducing substance, detectable by an assay for facteur 
thymique serique (9], which is considered, in other bioassay 
systems, to have characteristics distinct from the t hymic hor-
mones, facteur thymique serique, or thymopoietin [10]. The 
site of production of the hormone in these patients has not 
been determined, but production in the skin could not be 
excluded. 
For these cumulative reasons, we examined skin for the 
presence of thymic factors and elected to concentrate on the 
thymic hormone, thymopoietin (TP), which is chemically well 
characterized [11] and is detectable by a specific immunoassay 
[12]. TP I and TP II are closely re lated polypeptides isolated 
from bovine thymus [13] . They have been shown to induce 
markers of early T-cell differentiation in vitro (14], inhibit B-
cell differentiation in vitro [15), modulate mature lymphocytes 
in vitro [16), and a lso to impair neuromuscular transmission in 
vivo [13]. 
MATERIALS AND METHODS 
Antithymopoietin (Anti-TP) Antibody 
This antiserum was raised in rabbits as previously described [12]. In 
brief, TP was purified from bovine thymus [13] or spleen [17] and 
coupled with an equal weight of horse -y -globulin (Phentex, Kankakee, 
Illinois) using glutaraldehyde as the coupling reagent. Two hundred 
milligrams of coupled TP, emulsified in Freund's complete adjuvant 
(Difco, Detroit, Michigan), was injected intradermally into multiple 
sites in New Zealand white rabbits. Immunization was repeated bi-
weekly for 8 weeks, and the animals were bled on week 9. The anti-TP 
antibody is specific for TP and, in radioimmunoassay technique, does 
not react with a series of control peptides including insulin , bungaro-
toxin (Miami Serpentarium), histone (Sigma, St. Louis, Missouri) , a 
synthetic tridecapeptide fragment of TP, (residues 29-41) [18], and 
ubiqui tin (a substance found in many body tissues and capable of 
inducing nonselective different iation ofT and B cells) [19). 
Moncional Antibody OKT6 
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This antibody was generated in a mouse hybridoma system with 
human thymocytes as the immunogen. OKT6 recognizes 70% of thy-
mocytes representing the cortical cell population [20) and is also 
reactive with human Langerhans cells [21, 22]. 
Tissu.e Specimens 
Twelve biopsies of normal skin, 4 biopsies of thymus, and 2 biopsies 
of oral mucosa were obtained surgically in accordance with the regu-
lations of the Columbia University Investigat ional Review Board. Thy-
mus and oral mucosa biopsies and port ions of the skin biopsies were 
snap-frozen and maintained in liquid nitrogen. 
Epidermal Cell S uspension 
Single cell epidermal suspensions were prepared from the remaining 
skin tissue. The tissue was cut into small strips and incubated in crude 
trypsin (GIBCO) overnight at 4•c, after which time the epidermis was 
lifted from the dermis using fine forceps [23]. The epidermal sheets 
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were agitated in t rypsin EDTA (GJBCO) , and the resul t ing cell suspen-
sions were fil te red through gauze to remove cell aggregates and keratin. 
Furt her action of t he t ryps in was prevented by t he addition of 5 ml of 
feta l bovine serum. 
Epidermal Cell Culture 
Epiderma l cell suspensions from 4 skin specimens were put in to 
t issue culture by the technique of Eisinger et a l [23). The cells were 
resuspended in acid ified growth medium (pH 6) conta ining Dulbecco's 
modified Eagle's medium (GIBCO) supplemented with 10% fetal bovine 
serum (GJBCO), 10 ,.,gjml penicillin , 100 ,.,g/ml streptomycin, 2.5 ,.,g/ 
ml amphote ricin B, a nd 0.4 1' / ml hydrocortisone (Upjohn Co.) and 
plated at 5 x 106 cells/25 cm2 in tissue cu lture flasks (Falcon). After 1 
week, t he pH of t he medium was increased to 7.4 and the cultures were 
fed twice week ly t hereafter. Afte r 2 weeks of growth, t he cultures had 
achieved confluency and areas of keratinocyte stratification were evi-
dent. At this stage the growt h medium , as described above but lacking 
fetal bovine serum (thus excluding any possible exogenous source of 
TP), was substi tuted for t he normal growth medium. Cultures were fed 
with t his medium on a lternate days a nd t he cells were ha rvested at 2, 
4, 6, and 8 weeks by washing t he cultures in phosphate-buffered saline 
(PBS) lack ing calcium and magnesium (GIBCO), and t hen incubating 
for 5 min at 37"C in trypsin EDTA. T he harvested cells were resus-
pended in growth medium to stop the action of t he trypsin . 
Indirect Immunofluorescence of Separated Epidermal Cells 
Epidermal ce ll suspensions from freshly sepa rated human skin or 
from ha rvested t issue cultures, were resuspended in 2% bovine serum 
a lbumin (Sigma) in PBS at 10' ce lls/ml , and cytocentrifuge smea rs 
were prepared using a Shandon Southern Cytospin. Smears were fi xed 
in 5% acetic acid in met hanol for 10 min at 20"C, washed twice in 
PBS, a nd incubated with t he rabbit ant i-TP antiserum at a dilution of 
1:20 in PBS. After a 30-min wash in PBS, the smears were incubated 
for a n additional 30 min with the flu orescein -labeled goat antirabbi t 
a nt ibody (Meloy) used at a dilution of 1:8 in PBS. Following a fina l 
wash in PBS for 30 min , the cell smears were mounted in glycerine 
under a coverslip a nd examined using a Leitz Ortho-Lux II microscope 
wi t h a tluorescein vertica l illuminator. Five hundred cells were counted 
in each smear, and the percentage of ce lls showing cytoplasmic tluores-
cence was calculated. Human fibroblasts (donated by A. Andrews, M .D., 
Columbia Univers ity ), ha rvested from t issue cultures, were used as 
controls in place of t he epide rmal ce ll suspensions. As addit ional 
controls, nonimmune rabbit serum, rabbit a nti-ubiqui t in antiserum 
and rabbit anti-TP absorbed with a n equal volume of purified bovine 
TP III (1 mg/ml) at 1:20 dilutions, replaced t he ant i-TP antiserum. 
Double-Labeling Studies 
Freshly prepa red epidermal ce ll suspensions were incubated with 
OKT6 at a dilution of 1:400 in PBS for 30 min at 4 ·c. After 3 washes 
in PBS, the cells were incubated with rhodami ne-conjugated anti mouse 
antibody (Cappel Labs) at a dilution of 1:40 in PBS for 30 min at 4"C. 
Following an addi t ional 3 washes in PBS, the cells were resuspended 
in 2% bovine serum albumin and cytocentrifuge smears were prepa red. 
These smears were subsequently fixed and stained with the rabbit anti -
TP a nd fluorescein-conjugated goat anti rabbit ant ibody, as described 
above. Smears were examined using a Leitz Ortho-Lux II microscope 
with a fluorescein vertical illuminator a nd fluorescein a nd rhodam ine 
filters. 
Indirect Immunofluorescence of Tissue Sections 
Fou r-m icron cryostat sections of skin , oral mucosa, and thymus were 
fixed in acetone for 5 min t hen washed 30 min in PBS. The sections 
were incubated with t he rabbit ant i-TP at a dilution of 1:10 in PBS for 
30 min at room temperature in a humidity chamber. After a subsequent 
30-min wash in PBS, the sections were incubated with t he fluorescein -
conjugated goat antirabbit a ntiserum for 30 min at room temperature. 
Finally, t he sections were washed in PBS for 30 min, mounted in 
glycerine, and examined using a Leitz Ortho-Lux 11 microscope with a 
fluorescein vertical illuminator. As controls, nonimmune rabbit serum, 
rabbit anti-ubiqui t in , a nd rabbit anti-TP preabsorbed with purified 
bovine TP III were substituted for the anti-TP on the tissue sections. 
In addit ion, epithelial tissues, normal human parotid gland, prostate 
gland, small bowel, and large bowel were tested in pa rallel with skin , 
oral mucosa, or thymus. 
RESULTS 
Epidermal Cell Suspension 
Cells, positively labeling with the anti-TP antibody, showed 
bright green cytoplasmic fluorescence (Fig 1) in which a nuclear 
indentation could be readily identified. Positively labeled cells 
were identified in all 12 epidermal cell suspensions examined, 
representing 8-14% (mean 10%) of the epidermal cells. No 
positively labeled cells were found in the suspensions of fibro-
blasts or when epidermal cells were incubated with either 
nonimmune rabbit serum, anti-ubiquitin antibody, or anti-TP 
preabsorbed with thymopoietin. 
When suspensions of epidermal cells, grown in culture for 
variable times (2- 8 weeks), were examined, 2-5% of the cells 
showed bright cytoplasmic staining with the anti-TP anti-
serum. The percentage of labeled cells was unrelated to the age 
of the cell culture examined. 
Double Labeling 
In these preparat ions, cells labeled with anti-TP exhibited 
green, cytoplasmic fluorescence, while Langerhans cells labeled 
with OKT6 were identified by a granular, red, surface labeling. 
The Langer hans cell population, in the examined epithelial cell 
suspensions, represented 1- 2% of the cells present. None of 
these Langer hans cells stained with the anti-TP antiserum (Fig 
1) . The number of cells staining with the anti-TP antiserum 
was within the range found in single-labeling studies, indicating 
that incubation with OKT6 did not inhibit labeling of the cells 
with anti-TP antiserum . 
FI G 1. Cytocent rifuge smears of epidermal cells stained with OKT6 
and anti-TP. Gra nular surface labeling with OKT6 (->). Cytoplasmic 
labeling wi t h anti-TP (::::J . 
:f~ ~ -t::r-· . 
(,;.~-Is fl.... !; ' 
FIG 2. Skin stained with anti-TP demonstrating reactivity of basal 
layer of kerat inocytes in epidermis. 
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FIG 3. Skin stained with ant i-TP preabsorbed in purified TP dem-
onstrating no react ivity of basal layer of epidermis. 
Tissue Sections 
Skin and oral mucosa: In the normal human skin and oral 
mucosa specimens, basal keratinocytes consistent ly showed 
cytoplasmic staining with the anti-TP antibody (Fig 2) . Posi-
t ive cells were present as an almost continuous layer along the 
basement membrane·. In cont rol sections, in which nonimmune 
rabbit serum, anti-ubiquit in, or preabsorbed ant i-TP were used 
in place of the ant i-TP, weak background staining of the upper 
epidermis was observed, but t he basal cell layer was consistently 
unstained (Fig 3) . No labeling with t he ant i-TP was observed 
in other t issues examined (normal human parotid gland, pros-
tate gland , small bowel, and large bowel). 
Thymus: In normal human thymus, epit helial cells in t he 
interlobular septae and medulla demonstrated cytoplasmic 
staining with t he ant i-TP. T hese cells were often in close 
proximity to Hassall 's corpuscles (Fig 4) . 
DISCUSSION 
Although circumstant ial evidence has long suggested t hat the 
cutaneous and T -cell systems may normally interact in a bio-
logically dynamic fashion [24,25], it is on ly recently that sci-
entific data have begun to accumulate which elucidate such a 
normal skin- lymphocyte relationship. Specifically, it is now 
clear that the epidermis contains a small population of dendrit ic 
Langerhans cells which can efficient ly ini t iate a posit ive T -cell 
response to exogenous ant igen [26,27]. When t he functional 
integri ty of Langerhans cells is disturbed by ul t raviolet energy, 
topically applied ant igen may t hen preferent ially induce spe-
cific hyporesponsiveness to subsequent ant igenic challenge 
[28]. 
Rubenfeld et al were able to induce undiffe rent iated murine 
bone marrow cells to express terminal deoxyribonucleotidyl 
transfe rase (TdT) and membrane T hy-1, two markers of T -cell 
diffe rent iation, on cocultivation wit h syngeneic epidermis [5]. 
In the same study, a significant number of T dT-negative nor-
mal human peripheral blood T cells were also induced to 
become T dT -posit ive on incubation wit h cultured allogeneic 
human epidermis. 
All of t hese T dT -posit ive cells were stimulated to become 
lymphoblasts, by epidermal cocult ivation . It is of interest t hat 
T P induced TdT posit ivity but no blastogenesis, while mixed 
lymphocyte culture, ant igen or mitogen-stimulated cul tures, 
and control fibroblast and mammary epit helium cocul tures 
induced blastogenesis but not T dT positivity. 
Luger et al [8] have demonstrated t hat cultured murine 
keratinocytes produce an epidermal thymocyte-activating fac-
tor (ETAF) with functional and biochemical similarit ies to 
Interleukin (IL 1). IL 1 (lymphocyte activating factor) is pro-
duced by macrophages in response to a wide variety of stimu-
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F IG 4. T hymus stained with a nti-TP. Epit helia l ce lls showing cy-
top lasm ic label ing(-->). 
!ants, including endotoxin, phorbol esters, and lymphokines. It 
now appears that ET AF or IL 1 acts on a population of T cells, 
inducing expression of a membrane receptor for T -cell growth 
factor (IL 2) which is produced by eit her t he same or a separate 
population of T cells. IL 2 in turn stimulates the T cells, to 
which it has bound, to proliferate . It is, t herefore, notewort hy 
that all human lymphocytes induced to express TdT in the 
system of Rubenfeld et al [5] were also blasts, suggesting that 
the two studies may have ident ified the same phenomenon. 
It is conceivable that the induction of TdT posit ivi ty and 
blastogenesis by epidermal cult ures as shown by Rubenfeld et 
al may be brought about by the ETAF of Luger et al. The 
possibili ty that the TP-like molecule, ident ified as being pres-
ent in basal layer keratinocytes in the current study, may have 
ETAF-like activity and that t hese two epidermal factors may 
be chemically, as well as functionally, related is now being 
investigated in our laboratory. 
The suggestion that skin may exert a thymic inductive effect 
on T -cell maturation was subsequent ly strengthened by the 
findings of Haynes et al [29]. They noted that human "Thy-1," 
a marker of cortical t hymic T cells but not of normal blood T 
cells, is expressed on some T cells in human benign skin 
in fi ltrates such as delayed hypersensit ivity reactions. It has 
also been shown t hat human epidermal cells in cul ture induced 
expression of a t hymocyte different iation ant igen recognized 
by t he mouse monoclona l ant ibody (OKT6) in a population of 
neoplastic helper T cells [30]. · 
In our search for molecules that might induce such cellular 
events, we concent rated on TP for two reasons. First, t his 
family of substances has been chemically and functionally well 
characterized [11,12]. Second, ant igenic and structural similar-
it ies [1,2) between epit helial cells of t hymus and skin suggested 
t hat the latter t issue may be producing related fu nctional 
molecules. TP is a 49 amino acid polypept ide, isolated init ially 
from the t hymus, and selectively induces early T -cell differen-
t iation [31]. Two chemically distinct, but similar, forms of T P 
have been characterized from t he t hymus, T P I and TP II. 
These hormones share the same active pentapept ide site which 
has been synthesized [32]. TP I and TP II have also been 
shown to cause a slight impairment of neuromuscular t rans-
mission 24 h after injection [13]. More recent ly, another mol-
ecule, sp lenin (formally known as TP Ill) , has been isolated 
fro m an extrathymic site, t he spleen, and it cross- reacts in 
immunoassay with TP I and TP II. T his molecule is chemically 
distinguishable from TP I and T P II by a single amino acid 
alteration in t he active site region. Splenin is known to induce 
both early B- and T -cell differe nt iation but plays no part in 
neuromuscular t ransmission.:j: 
t Audhya T, Scheid M, Goldste in G. Manuscript in prepa ration. 
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In a recent study by Ranges et a! [33] aberrations apparen t 
in t he splenic T -cell populations of nufnu mice (decreased total 
number of T cells, a ll of which a re TL +, with li ttle or no 
diversification in to Ly-1 a nd Ly-23 subsets) were part ia lly 
corrected by daily i.p. injections of TP. These resul ts serve as 
additional evidence of a n in vivo role of TP in T -cell differen-
t iat ion . 
In the current study, we have demonstrated t hat a molecule, 
which is a lso indistinguishable from TP by immunoassay, is 
presen t in a nother major extrathymic s ite, the epidermis . Two 
to 14% of huma n epidermal cells possess t his TP-like substance 
a nd t hese ce lls maintain t he substance in t issue culture, under 
cu lt ure conditions in which exogenous sources of TP a re ex-
cluded. S uch studies suggest t hat TP-like substance is endog-
enously produced rather t han concentrated from t he external 
environment. In sit u determinations revea led that t hese cells 
are the basal keratinocytes of t he epidermis. 
The a nti-TP antibody, although heterologous, was demon-
strated to have selective activity for the basal layer population 
o nly. The suprabasalar layer was negative a nd the use of con trol 
nonimmune rabbit serum and rabbit anti-ubiquitin a ntiserum 
rules out the possible presence in t he rabbit serum of nonspe-
cific antibodies again st different antigenic determinants t hat 
may occur on intermediate-sized filaments of the cytoskeleton 
of keratinocytes . Generation of monoclonal a ntibodies against 
TP determina nts is now being attempted (G. Goldstein, unpub-
lis hed data). 
It will now be importan t to determine whether t he in vitro 
inductive int1uence of epidermal cells on T-cell differentiation 
can be traced to this TP-like substance, to discover whether 
t his substance represents TP I, TP II, or TP III or is chemically 
distinct, a nd to examine its relationship to t he factor of Luger 
et a l [8]. The possibility t hat t he skin may contribute to normal 
postthymic differentiation [34] is particularly provocative. If 
such a mec hanism ex ists, it may expla in t he affinity ofT cells 
for the skin a nd the epidermotropism seen in malignant T -cell 
disease. On a more general level, it will be of interest to 
determine whether this putative immunoregulator molecule in 
skin a ffects now recognized interact ions between T cells a nd 
epidermis or whether it se rves a distinct function unrelated to 
immunoregu lation . 
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